Ewa Janczewska
Overview
Explore the profile of Ewa Janczewska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Bommel F, Verbinnen T, Agarwal K, Vanwolleghem T, Lampertico P, Buti M, et al.
Hepatol Commun
. 2025 Feb;
9(3).
PMID: 40008890
Background: In the nucleos(t)ide analog (NA)-control arm of the REEF-2 study (NCT04129554), virologic relapse (confirmed increase in HBV DNA >2000 IU/mL) and biochemical flare (ALT increases ≥3× upper limit of...
2.
Wlosowicz A, Zmudka K, Palczynska-Gwiazdowicz E, Panczyk J, Blaut M, Swiatkowska W, et al.
Clin Exp Hepatol
. 2025 Jan;
10(2):137-143.
PMID: 39845350
Aim Of The Study: Hepatitis delta virus (HDV) causes the most aggressive and rapidly progressive form of viral hepatitis. However, detailed data about epidemiology and risk factors in Polish population...
3.
Flisiak R, Zarebska-Michaluk D, Martonik D, Janocha-Litwin J, Berak H, Sitko M, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768565
The wave of wartime migration from Ukraine has raised a number of concerns about infectious diseases, the prevalence of which is higher in Ukraine than in host countries, with hepatitis...
4.
Janczewska E, Janota B
Clin Exp Hepatol
. 2024 Dec;
10(3):145-149.
PMID: 39697372
Liver injury resulting from the use of dietary supplements, herbs, and commonly available medications is a problem that is becoming increasingly significant due to the widespread availability and growing popularity...
5.
Dabrowska M, Jaroszewicz J, Sitko M, Janocha-Litwin J, Zarebska-Michaluk D, Janczewska E, et al.
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272972
Background: Over the past years, the introduction of direct-acting antivirals (DAAs) revolutionized chronic hepatitis C treatment. We aimed to characterize and assess treatment efficacy in three specific groups of patients...
6.
Buti M, Heo J, Tanaka Y, Andreone P, Atsukawa M, Cabezas J, et al.
J Hepatol
. 2024 Aug;
82(2):222-234.
PMID: 39214467
Background & Aims: Bepirovirsen, an antisense oligonucleotide, induces sustained reductions in hepatitis B surface antigen (HBsAg) and HBV DNA to below the lower limit of quantification (<LLOQ) in a subset...
7.
Brzdek M, Zarebska-Michaluk D, Kukla M, Janocha-Litwin J, Dybowska D, Janczewska E, et al.
Pharmacol Rep
. 2024 Aug;
76(5):1114-1129.
PMID: 39162985
Background: Hepatitis C virus (HCV) infection affects 50 million people worldwide with around 242,000 deaths annually, mainly due to complications such as cirrhosis and hepatocellular carcinoma (HCC). Portal hypertension (PH)...
8.
Flisiak R, Zarebska-Michaluk D, Janczewska E, Parfieniuk-Kowerda A, Mazur W, Sitko M, et al.
J Viral Hepat
. 2024 Aug;
31(11):677-685.
PMID: 39109641
To date, the effectiveness of direct-acting antivirals (DAAs) discontinued before 4 weeks has not been analysed in routine clinical practice. The study aimed to determine whether such a short therapy...
9.
Tronina O, Brzdek M, Zarebska-Michaluk D, Lorenc B, Janocha-Litwin J, Berak H, et al.
Clin Exp Hepatol
. 2024 May;
9(4):320-334.
PMID: 38774196
Aim Of The Study: The aim is to summarize the effectiveness and safety of genotype-specific and pangenotypic hepatitis C virus (HCV) treatments in patients with renal failure. Material And Methods:...
10.
Piekarska A, Berkan-Kawinska A, Berak H, Mazur W, Sitko M, Parfieniuk-Kowerda A, et al.
Expert Rev Anti Infect Ther
. 2024 May;
22(9):775-780.
PMID: 38722307
Background: The aim of this study was to evaluate the real-life efficacy of pangenotypic antivirals in HIV-HCV-positive patients. Research Design And Methods: The analysis included 5650 subjects who were treated...